Eisai got favorable injunction for preventing generic version of Aricept

Teva Pharmaceutical is not allowed to start selling generic version of Aricept Anti Alzhimer’s drug. Teva had file PIV ANDA for launching generic version of Eisai’s product Aricept.
According to Bloomberg, Eisai’s biggest product with $2.16 billion in worldwide sales in the year ended in march 2007.
The case is Eisai Co. v. Teva Pharmaceuticals USA Inc., [...]